Watch Ticker

HUTCHMED (China) Limited American Depositary Shares

Go to HUTCHMED (China) Limited American Depositary Shares Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$3.2 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a po...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

HUTCHMED (China) Limited - HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade —

Related tickers: HCM, HCM.

Read Full Article

HUTCHMED (China) Limited - HUTCHMED Highlights Data to be Presented at AACR Congress 2024

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the upcoming American Association of Cancer Research (“AACR”) Annual Meeting 2024, taking place on April 5-10, 2024 in San Diego, California.

Related tickers: HCM, HCM.

Read Full Article

Trending Tickers

DATS

XNAS

$1.23

(%)

LASE

XNAS

$2.19

(%)

NYCB

XNYS

$3.07

(%)

PACW

XNAS

$7.54

(%)

MLGO

XNAS

$0.00

(%)